246 related articles for article (PubMed ID: 35599266)
21. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
[TBL] [Abstract][Full Text] [Related]
23. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.
Al-Omair A; Masucci L; Masson-Cote L; Campbell M; Atenafu EG; Parent A; Letourneau D; Yu E; Rampersaud R; Massicotte E; Lewis S; Yee A; Thibault I; Fehlings MG; Sahgal A
Neuro Oncol; 2013 Oct; 15(10):1413-9. PubMed ID: 24057886
[TBL] [Abstract][Full Text] [Related]
25. Postoperative Stereotactic Body Radiotherapy for Spinal Metastasis and Predictors of Local Control.
Blakaj DM; Palmer JD; Dibs K; Olausson A; Bourekas EC; Boulter D; Ayan AS; Cochran E; Marras WS; Mageswaran P; Katzir M; Yildiz VO; Grecula J; Arnett A; Raval R; Scharschmidt T; Elder JB; Lonser R; Chakravarti A; Mendel E
Neurosurgery; 2021 Apr; 88(5):1021-1027. PubMed ID: 33575784
[TBL] [Abstract][Full Text] [Related]
26. Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases.
Mantel F; Glatz S; Toussaint A; Flentje M; Guckenberger M
Strahlenther Onkol; 2014 Nov; 190(12):1141-8. PubMed ID: 24969225
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262
[TBL] [Abstract][Full Text] [Related]
28. Mature Imaging-Based Outcomes Supporting Local Control for Complex Reirradiation Salvage Spine Stereotactic Body Radiotherapy.
Detsky JS; Nguyen TK; Lee Y; Atenafu E; Maralani P; Husain Z; Tseng CL; Myrehaug S; Soliman H; Sahgal A
Neurosurgery; 2020 Sep; 87(4):816-822. PubMed ID: 32374852
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
[TBL] [Abstract][Full Text] [Related]
31. Cumulative dose, toxicity, and outcomes of spinal metastases re-irradiation : Systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Pontoriero A; Lillo S; Caravatta L; Bellafiore F; Longo S; Lattanzi E; Parisi S; Fiorica F; Massaccesi M
Strahlenther Onkol; 2021 May; 197(5):369-384. PubMed ID: 33635395
[TBL] [Abstract][Full Text] [Related]
32. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials.
Tao R; Bishop AJ; Brownlee Z; Allen PK; Settle SH; Chang EL; Wang X; Amini B; Tannir NM; Tatsui C; Rhines LD; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1405-1413. PubMed ID: 27209509
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic body radiotherapy with helical tomotherapy for pain palliation in spine metastasis.
Kim MS; Keum KC; Cha JH; Kim JH; Seong JS; Lee CG; Nam KC; Koom WS
Technol Cancer Res Treat; 2013 Aug; 12(4):363-70. PubMed ID: 23448578
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
36. Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local Control.
Abugharib A; Zeng KL; Tseng CL; Soliman H; Myrehaug S; Husain Z; Maralani PJ; Larouche J; Cheung P; Emmenegger U; Atenafu EG; Sahgal A; Detsky JS
Neurosurgery; 2022 Jun; 90(6):743-749. PubMed ID: 35343467
[TBL] [Abstract][Full Text] [Related]
37. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.
Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR
Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017
[TBL] [Abstract][Full Text] [Related]
38. Radiosurgery for Treatment of Renal Cell Metastases to Spine: A Systematic Review of the Literature.
Smith BW; Joseph JR; Saadeh YS; La Marca F; Szerlip NJ; Schermerhorn TC; Spratt DE; Younge KC; Park P
World Neurosurg; 2018 Jan; 109():e502-e509. PubMed ID: 29038086
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases.
Attiah M; Sandler K; Medina R; Gaonkar B; McArthur D; Farha G; Selch M; De Salles A; Tenn S; Agazaryan N; Lee P; Steinberg M; Lu D; Macyszyn L; Kaprealian T
World Neurosurg; 2020 Apr; 136():e68-e74. PubMed ID: 31733382
[TBL] [Abstract][Full Text] [Related]
40. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group.
Chang UK; Cho WI; Kim MS; Cho CK; Lee DH; Rhee CH
Acta Oncol; 2012 May; 51(5):589-95. PubMed ID: 22414095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
